|
|
||||||||
1 Albert Einstein College of Medicine, Department of Epidemiology and Population Health, 1300 Morris Park Avenue, Bronx, NY 10461, USA
2 University of California, San Francisco, San Francisco, CA, USA
3 Maimonides Medical Center, Brooklyn, NY, USA
4 Southern Illinois University School of Medicine, Springfield, IL, USA
5 The Henry M. Jackson Foundation, Rockville, MD, USA
6 University of Southern California, Los Angeles, CA, USA
7 Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
8 National Institute of Child Health and Human Development, Bethesda, MD, USA
Correspondence
Nicolas F. Schlecht
nschlech{at}aecom.yu.edu
Highly oncogenic human papillomavirus (HPV) 16 and 18 variants might be expected to be particularly aggressive in HIV-positive women. The association of HPV16 and 18 variant lineages with race, human immunodeficiency virus (HIV) coinfection, CD4+ T-cell count, HIV-RNA level, time-to-clearance of HPV infection and presence of squamous intraepithelial lesions (SIL) among women in the Women's Interagency HIV Study was studied. Subjects were followed semi-annually with Pap smear and cervicovaginal lavage (CVL). HPV DNA was detected in CVLs using MY09/11 L1 PCR assay. Specimens positive for HPV16/18 underwent E6 PCR and sequencing to determine the variant present. Specimens from 195 HPV16- and 162 HPV18-positive women were classified into variant lineages based on sequencing results. African variants of HPV16 and HPV18 were significantly more prevalent among African-Americans than among Caucasians [42 versus 14 % (P=0·001) and 60 versus 13 % (P<0·001), respectively]. However, it was not possible to detect associations between the HPV16 or 18 variant lineages and other factors studied. African variants of HPV16/18 were more common in women of African descent living outside Africa, which could reflect mixing behaviours and/or immunogenetic factors. However, in a large population of HIV-infected women, the variant of HPV16 or 18 was unrelated to persistence of infection or presence of SIL. If non-European variants are more oncogenic, the effect may involve a late stage in cervical tumorigenesis.
This article has been cited by other articles:
![]() |
M. L. Tornesello, M. L. Duraturo, P. Giorgi-Rossi, M. Sansone, R. Piccoli, L. Buonaguro, and F. M. Buonaguro Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women J. Gen. Virol., June 1, 2008; 89(6): 1380 - 1389. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Xi, L. A. Koutsky, A. Hildesheim, D. A. Galloway, C. M. Wheeler, R. L. Winer, J. Ho, and N. B. Kiviat Risk for High-Grade Cervical Intraepithelial Neoplasia Associated with Variants of Human Papillomavirus Types 16 and 18 Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 4 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Xi, N. B. Kiviat, A. Hildesheim, D. A. Galloway, C. M. Wheeler, J. Ho, and L. A. Koutsky Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. J Natl Cancer Inst, August 2, 2006; 98(15): 1045 - 1052. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |